This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Drug Conjugates
August 16-17, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu

Gerold Meinhardt
Vice President Asset & Portfolio Management at Daiichi Sankyo Inc., USA
Speaker

Agenda Sessions

  • Panel Discussion: Overviewing the Current ADC Landscape: What Can we Expect from the Future of ADC Drug Development?

    , 08:35
    View Session

At this event

Prev
Next
Paul Moore
Chief Scientific Officer
Zymeworks, Canada

See Gerold at Antibody Drug Conjugates